Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial
about
sameAs
Anticoagulants for secondary prevention after acute myocardial infarction: lessons from the past decadeDrug therapy for prevention of recurrent myocardial infarctionWarfarin and aspirin versus aspirin alone in patients with acute myocardial infarction: a pilot studyAnticoagulation in the elderlyBleeding profiles of anticoagulants, including the novel oral direct thrombin inhibitor ximelagatran: definitions, incidence and management.Ximelagatran: an oral direct thrombin inhibitor.Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the NetherlandsPotential role of rivaroxaban in patients with acute coronary syndromeAspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?Anticoagulant management in the cardiovascular setting.The "dual-pathway" strategy after acute coronary syndrome: rivaroxaban and antiplatelet agents in the ATLAS ACS 2-TIMI 51 trial.Relation of PAI-1 and TPA genes polymorphisms to acute myocardial infarction and its outcomes in Egyptian patients.Efficacy and safety of aspirin combined with warfarin after acute coronary syndrome : A meta-analysis.Antiplatelet therapies in patients with an indication for anticoagulation.Treatment of ST-elevation myocardial infarction.Do patients with heart failure appropriately undergo invasive procedures post-myocardial infarction? Results from a prospective multicentre study.Biphasic release of protein from polyethylene glycol and polyethylene glycol/modified dextran microspheres.Interactions between cardiovascular and cerebrovascular diseaseScintigraphic parameters with emphasis on perfusion appraisal in rest 99mTc-sestamibi SPECT in the recovery of myocardial function after thrombolytic therapy in patients with ST elevation myocardial infarction (STEMI)
P2860
Q26824864-0E93084E-0506-4BEE-A181-A5FB6E47ABADQ28165520-52C00EC0-2116-439E-BD79-2DC18C185BE8Q28167090-F1CD812E-3C38-4F17-9B70-5F51249E6042Q28196884-816ACCA1-DA95-400B-A89B-C297A60B55B6Q35878355-FAEB3939-FF1D-4313-B6AB-4B9D12080F59Q35895188-77C69179-3DA9-4873-B01F-84DF5CBF343CQ36173045-DEFAE06B-7E3F-445A-85FD-AA9705D6BD83Q36433688-46DC642E-F44C-474C-A297-655A243C04DBQ37162895-2CAF3185-FBC3-4610-878A-1B148E067D25Q37914925-5AE12D55-C191-4398-B6A7-0797CADFEA1FQ38217362-E87D4506-6AF6-463E-80FB-E20AE1FFBF92Q38852956-41AB7D45-226F-4141-891C-0378202F2A56Q38992107-820BD8D4-752A-42FF-AF4E-E324F15C6303Q38995602-8879FE8B-367E-4393-8B9B-4A2D7749174CQ40076747-5D74F58D-90DF-40ED-9FC2-D2D2053B39BBQ40105240-DD9FA338-D08C-41FF-B565-29822A79AF3DQ44284251-541EFBA2-BD9F-4975-8E04-0D30243AB241Q56979792-B41BB0B4-38D4-4125-AFB7-D5E29BAD5B59Q58618884-B92E57C7-7911-4D8E-8FA9-3FCC4C5504C8
P2860
Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Aspirin plus coumarin versus a ...... Thrombolysis (APRICOT)-2 Trial
@ast
Aspirin plus coumarin versus a ...... Thrombolysis (APRICOT)-2 Trial
@en
Aspirin plus coumarin versus a ...... Thrombolysis (APRICOT)-2 Trial
@nl
type
label
Aspirin plus coumarin versus a ...... Thrombolysis (APRICOT)-2 Trial
@ast
Aspirin plus coumarin versus a ...... Thrombolysis (APRICOT)-2 Trial
@en
Aspirin plus coumarin versus a ...... Thrombolysis (APRICOT)-2 Trial
@nl
prefLabel
Aspirin plus coumarin versus a ...... Thrombolysis (APRICOT)-2 Trial
@ast
Aspirin plus coumarin versus a ...... Thrombolysis (APRICOT)-2 Trial
@en
Aspirin plus coumarin versus a ...... Thrombolysis (APRICOT)-2 Trial
@nl
P2093
P921
P3181
P1433
P1476
Aspirin plus coumarin versus a ...... Thrombolysis (APRICOT)-2 Trial
@en
P2093
Ad J van Boven
Don P Hertzberger
Freek W A Verheugt
Gerrit Veen
Gérard J H Uijen
Hans E Luijten
Marc A Brouwer
Paul J P C van den Bergh
Ralf P J W Vromans
Wim R M Aengevaeren
P304
P3181
P356
10.1161/01.CIR.0000024408.81821.32
P407
P577
2002-08-06T00:00:00Z